Medical Oxygen Air Liquide Healthcare Ireland

Oxygen, the active ingredient in Medical Oxygen Air Liquide Healthcare Ireland, is a medical gas presented as a medical gas for inhalation use. It is used to increase tissue oxygenation in patients with hypoxemia, respiratory distress and other acute care settings.

GNH USA supplies Medical Oxygen Air Liquide Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Medical Oxygen is a respiratory therapy gas used to correct low blood‑oxygen levels and support breathing in acute and chronic conditions. - Hypoxemia: restores adequate arterial oxygen saturation. - Respiratory distress: alleviates shortness of breath and improves gas exchange. - Acute care (post‑operative, trauma): provides supplemental oxygen to maintain tissue oxygenation during critical periods.

Supplemental oxygen may be associated with a range of adverse reactions, most of which are related to delivery method or excessive exposure.

Common Side Effects: - Nasal dryness or irritation. - Headache. - Fatigue or drowsiness. - Cough. - Mild chest discomfort.

Serious or Rare Side Effects: - Oxygen toxicity (pulmonary or central nervous system). - Fire hazard when used near open flames. - Hypercapnia in patients with chronic CO₂ retention. - Barotrauma from high‑pressure delivery systems.

Medical Oxygen should be used under professional supervision with attention to patient‑specific factors. - Patient assessment: verify indication and monitor oxygen saturation. - Flow rate adjustment: titrate to target SpO₂ to avoid hyperoxia. - Contraindications: avoid in patients with known oxygen toxicity risk. - Interaction with sedatives: monitor respiratory drive closely. - Storage: Store at ambient temperature: keep cylinders upright, protect from heat, direct sunlight and physical damage.

Oxygen can modify the effects of certain medications and substances.

Major Interactions (Avoid): - Nitrous oxide: increased risk of combustion. - Paraquat: potentiates pulmonary toxicity. - Bleomycin: may exacerbate lung injury.

Moderate Interactions (Monitor Closely): - Sedatives and opioids: enhanced respiratory depression. - Certain chemotherapy agents (e.g., cyclophosphamide): monitor for pulmonary side effects. - Carbon monoxide exposure: may mask hypoxia signs.